Experimental cerebral venous thrombosis: evaluation using magnetic resonance imaging

Area of Science:

• Neuroscience
• Radiology
• Pathophysiology

Background:

• Cerebral venous thrombosis (CVT) is a rare but serious condition.
• Understanding CVT pathophysiology is crucial for effective treatment.
• Advanced MRI techniques offer insights into acute brain injury.

Purpose of the Study:

• To characterize the pathophysiology of experimental cerebral venous thrombosis (CVT) in rats.
• To evaluate the utility of diffusion-weighted imaging (DWI), perfusion imaging, and conventional MRI in monitoring CVT.
• To assess the effects of tissue plasminogen activator (t-PA) on CVT-induced changes.

Main Methods:

• Cerebral venous thrombosis (CVT) induced in rats via superior sagittal sinus (SSS) ligation and thrombogenic agent injection.
• Monitoring using diffusion-weighted imaging (DWI), dynamic contrast-enhanced perfusion imaging, and conventional MRI.
• Histopathological analysis (Evans blue, hematoxylin-eosin) and t-PA treatment in a subgroup.

Main Results:

• MRI detected parenchymal lesions in rats with additional cortical venous involvement.
• DWI revealed early cytotoxic edema (ADC decline) followed by vasogenic edema.
• Perfusion imaging showed parasagittal perfusion deficits.
• t-PA treatment partially reversed DWI hyperintensity, indicating tissue recovery.

Conclusions:

• Experimental CVT is characterized by early cytotoxic edema followed by vasogenic edema.
• DWI is sensitive to early pathological changes in CVT.
• t-PA treatment demonstrated partial reversal of DWI signal changes, suggesting therapeutic potential.
• Findings support combining cytoprotective drugs with anticoagulant or thrombolytic therapy for CVT.